Legal explainer

Is Psilocin Legal Under Federal and State Law?

Psilocin (listed as psilocyn) is Schedule I federally, like psilocybin: 21 CFR 1308.11(d)(30), DEA code 7438. State decriminalization does not change the federal listing.

Psilocin is federally Schedule I. The federal regulation and Controlled Substances Act list the substance federally. The 1971 Convention on Psychotropic Substances lists it separately. The regulation and statute spell the name "Psilocyn". The treaty uses "psilocine" or "psilotsin."

The statute, regulation and treaty text were read on November 15, 2026.

Psilocin is a federal Schedule I controlled substance under 21 CFR 1308.11(d)(30). The regulation uses "Psilocyn" and assigns Drug Enforcement Administration (DEA) code 7438. Under 21 USC 812(c), psilocyn also appears in the statute's Schedule I(c) list.

Possession, manufacture, and distribution are federal offenses outside DEA-registered research, including Food and Drug Administration (FDA)-authorized trials conducted under 21 USC 823(n), and other settings the statute authorizes. 21 USC 841(a)(1) makes manufacture and distribution of a controlled substance unlawful except as the statute authorizes, and 21 USC 844(a) does the same for possession. 21 USC 822 requires annual registration for people who manufacture or distribute controlled substances. A state's decision to decriminalize conduct does not remove psilocyn from the federal list in 21 CFR 1308.11.

Psilocybin has its own federal Schedule I entry at 21 CFR 1308.11(d)(29), with DEA code 7437. The regulation lists the two substances in separate entries. See is psilocybin legal in the US.

Jurisdiction or sourcePsilocin (psilocyn)PsilocybinSource
Federal regulationSchedule I, entry (30), Drug Enforcement Administration (DEA) code 7438.Schedule I, entry (29), DEA code 7437.21 CFR 1308.11(d)
Current federal statuteSchedule I(c), entry (16), spelled "Psilocyn."Schedule I(c), entry (15).21 USC 812(c)
1970 federal actSchedule I(c), entry (16), spelled "Psilocyn."Schedule I(c), entry (15).Public Law 91-513, section 202
1971 United Nations conventionSchedule I, named "psilocine" or "psilotsin."Schedule I, named "PSILOCYBINE."Convention on Psychotropic Substances, Schedule I
Washington state exampleState Schedule I, entry (c)(29), spelled "psilocyn."State Schedule I, entry (c)(28).RCW 69.50.204(c)

What Schedule I Means for Psilocin

Federal Schedule I status places psilocyn under the classification criteria in 21 USC 812(b)(1). Congress set three criteria for placement: high potential for abuse, no currently accepted medical use in treatment in the United States, and lack of accepted safety for use under medical supervision. Those are statutory criteria for the schedule. They are not findings from testing conducted for this page.

See Controlled Substances Act and psychedelics. For manufacture and distribution, 21 USC 822(a)(1) requires a registration issued annually by the Attorney General. That registration requirement does not make general possession lawful.

Federal scheduling and permission for particular research are different questions under 21 USC 812 and 21 USC 823. A Schedule I research application has a statutory review path, while psilocyn remains listed in Schedule I. Neither provision establishes a general-use exemption.

Why Psilocybin and Psilocin Are Listed Together

The federal statute, federal regulation, and 1971 convention each name psilocybin and psilocin in their Schedule I lists. The statute and regulation spell the second name "Psilocyn." The convention calls it "psilocine" and also gives "psilotsin" as a name.

Section 202 of Public Law 91-513, approved October 27, 1970, placed psilocybin at entry (15) and psilocyn at entry (16) in Schedule I(c). The current 21 USC 812(c) retains those entries, and 21 CFR 1308.11(d) assigns each substance a separate DEA code. A reader checking a legal text therefore needs to account for both names.

Why lawmakers listed the two substances together is not stated in the text cited here. The statute, regulation, and treaty text cited here provide no chemical or metabolic explanation for their paired entries. For the broader question behind why magic mushrooms are illegal, the federal lists establish the classification without supplying that explanation.

The 1971 convention's Article 7 calls for tightly restricted handling of Schedule I substances by treaty parties. Congress stated in 21 USC 801a that the convention is not self-executing and that United States obligations require legislation. The treaty's list therefore should not be treated as a substitute for the domestic statute and regulation.

Is Psilocin Legal Under State Law?

State laws can treat psilocin differently without changing its federal Schedule I entry under 21 CFR 1308.11(d)(30). Washington's RCW 69.50.204(c) supplies one state-listing example: it places psilocybin at (c)(28) and psilocyn at (c)(29) in the state's Schedule I. Washington's listing is separate from the federal one.

Colorado's Proposition 122 decriminalized personal use, possession, and gifting of psilocybin and psilocin for adults 21 and older under state law, according to the Colorado legal-status record. That record says licensed healing centers offer facilitated psilocybin sessions. Retail sale and distribution are not permitted. The same record states that federal Schedule I continues to apply.

Oregon's Measure 109 established psilocybin services with licensed facilitators at licensed service centers for clients 21 and older, according to the Oregon legal-status record. The Oregon record says a physician referral is not required. It does not report that Oregon's service program changes psilocin's federal classification, and it states that federal Schedule I still applies.

The Colorado and Oregon records describe different state approaches. Colorado's record expressly names psilocin in its decriminalization provision. The Oregon service-program record describes psilocybin services. Neither state record removes psilocyn from 21 CFR 1308.11.

Who Can Lawfully Handle Schedule I Substances

Federal law provides a registration process for Schedule I research under 21 USC 823(g)(2)(A). Applications from practitioners seeking to conduct Schedule I research go to the Secretary of Health and Human Services for review of the practitioner's qualifications and the research protocol. That process addresses research applications, not general possession.

21 USC 822(a)(1) separately requires annual registration for anyone who manufactures or distributes a controlled substance. The 1971 convention's Article 7 also calls for special licensing or prior authorization, close supervision, and restricted purposes for Schedule I substances. Congress stated in 21 USC 801a that United States treaty obligations must be carried out through legislation.

The Religious Freedom Restoration Act (RFRA) permits a person to assert a religious-exercise claim or defense in a judicial proceeding. Under 42 USC 2000bb-1, the government must meet the statute's compelling-interest and least-restrictive-means test when it substantially burdens religious exercise. A claim is decided case by case. The cited text announces no general RFRA exemption for mushroom use.

The RFRA and psychedelics page addresses that distinct legal question. Neither a research-registration provision nor the ability to raise a RFRA claim establishes a general exemption from psilocyn's federal Schedule I listing.

Federal Status and the Condition That Could Change It

For a reader asking whether psilocin is legal, the federal answer is that psilocyn remains Schedule I under 21 USC 812(c) and 21 CFR 1308.11(d)(30). Possession, manufacture, and distribution are federal offenses outside DEA-registered research, including FDA-authorized trials conducted under 21 USC 823(n), and other settings the statute authorizes under 21 USC 841(a)(1) and 21 USC 844(a). The 1971 convention also lists the substance, but 21 USC 801a says the treaty is not self-executing.

State programs do not change the federal listing, and an individual case needs a licensed attorney.

The federal scheduling answer would change if Congress changed the statute or the Drug Enforcement Administration transferred or removed psilocyn through the process in 21 USC 811. A court-recognized exemption could change the answer for a particular claimant under 42 USC 2000bb-1 without changing the general schedule. For the question "is psilocin legal" in a particular state, check the state-by-state legal status tool.

Frequently Asked Questions

What schedule is psilocybin?

Psilocybin is federally Schedule I under 21 USC 812(c) and 21 CFR 1308.11(d)(29). The regulation assigns it DEA code 7437.

Is psilocybin a Schedule I drug according to the DEA?

Yes. The Drug Enforcement Administration's regulation, 21 CFR 1308.11(d)(29), lists psilocybin in Schedule I under code 7437.

Is psilocin treated differently from psilocybin under the law?

Both substances have separate federal Schedule I entries under 21 CFR 1308.11(d). Whether a state provision names psilocin, psilocybin, or both depends on that provision's text. Colorado's state-law decriminalization record names both.

Does Colorado decriminalization make psilocin legal federally?

No. Colorado's Proposition 122 decriminalized specified personal conduct involving psilocin for adults 21 and older under state law, according to the Colorado legal-status record. Psilocyn remains federally Schedule I under 21 CFR 1308.11(d)(30).

Can researchers lawfully use psilocin?

Research can proceed within applicable registration and authorized trial settings under the federal framework. Under 21 USC 823(g)(2)(A), applications from practitioners seeking Schedule I research registration receive review of qualifications and the research protocol. That provision does not authorize general use.

Can psilocin be rescheduled?

Yes, if the findings and procedures required by 21 USC 811 are met. That statute permits the Attorney General to transfer or remove a substance by rule after the required process. It does not establish that psilocyn will be rescheduled. Congress could also change the statutory listing.

Get psilocybin research & policy updates

New trials, FDA decisions, and legal changes for psilocybin — delivered when they happen.

Free. No spam. Unsubscribe anytime.

← Back to all therapy guides

Sources

  1. United States Congress. 21 USC 812: Schedules of Controlled Substances. United States Code. Legal Information Institute.
  2. Drug Enforcement Administration. 21 CFR 1308.11: Schedule I. Electronic Code of Federal Regulations. eCFR.
  3. United States Congress. Public Law 91-513: Comprehensive Drug Abuse Prevention and Control Act of 1970. United States Statutes at Large, 1970. GovInfo.
  4. United States Congress. 21 USC 801a: Congressional Findings and Declarations. United States Code. Legal Information Institute.
  5. United Nations. Convention on Psychotropic Substances, 1971. United Nations Treaty Text, 1971. United Nations Office on Drugs and Crime.
  6. United States Congress. 21 USC 811: Authority and Criteria for Classification of Substances. United States Code. Legal Information Institute.
  7. United States Congress. 21 USC 822: Persons Required to Register. United States Code. Legal Information Institute.
  8. United States Congress. 21 USC 823: Registration Requirements. United States Code. Legal Information Institute.
  9. United States Congress. 42 USC 2000bb-1: Free Exercise of Religion Protected. United States Code. Legal Information Institute.
  10. Washington State Legislature. RCW 69.50.204: Schedule I. Revised Code of Washington. Washington State Legislature.
  11. United States Congress. 21 USC 841: Prohibited Acts A. United States Code, read November 15, 2026. Legal Information Institute.
  12. United States Congress. 21 USC 844: Penalties for Simple Possession. United States Code, read November 15, 2026. Legal Information Institute.